>
Procter & Gamble Health logo

PGHL - Procter & Gamble Health Share Price

₹5863.5 -413.7  -6.6%

Last Trade - 11:29am

Sector
Healthcare
Size
Mid Cap
Market Cap £1.02bn
Enterprise Value £987.2m
Revenue £91.1m
Position in Universe 275th / 3105
Bullish
Bearish
Unlock PGHL Revenue
Momentum
Relative Strength (%)
1m +2.48%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -16.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
8,675 9,395 10,298 7,115 8,490 13,559 +9.3%
-22.7 +25.7 +56.4 -28.0 +58.4 +164.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020, Procter &Gamble Health Ltd revenues increased 9% to RS5.04B. Netincome increased 72% to RS1.27B. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Net income benefitedfrom Other expenses decrease of 26% to RS1.07B (expense).Basic Earnings per Share excluding Extraordinary Itemsincreased from RS44.56 to RS76.60.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for PGHL
Graphical History

Revenue

PGHL Revenue Unlock PGHL Revenue

Net Income

PGHL Net Income Unlock PGHL Revenue

Normalised EPS

PGHL Normalised EPS Unlock PGHL Revenue

PE Ratio Range

PGHL PE Ratio Range Unlock PGHL Revenue

Dividend Yield Range

PGHL Dividend Yield Range Unlock PGHL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
PGHL EPS Forecasts Unlock PGHL Revenue
Profile Summary

Procter & Gamble Health Limited, formerly Merck Limited, is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments. The Company operates through two segments: Pharmaceuticals and Chemicals. Its geographical segments include Domestic and Exports. Its Pharmaceutical segment consists of ethicals used in the treatment of cardiovascular and metabolic diseases, consumer healthcare products and vitamins-based formulations. The Pharmaceuticals segment has two business divisions: BioPharma and Consumer Health. Its Chemicals segment includes bulk drugs and pigments. It consists of two divisions: Pharma Chem Solutions and Performance Materials. The Pharm Chem Solutions division offers products and solutions, including active pharmaceutical ingredients, excipients. It offers products, such as vitamin E, guaizulene, thaiminedisulphide (TDS).

Directors
Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated April 26, 1967
Public Since November 21, 1993
No. of Shareholders: 50,825
No. of Employees: 1,093
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange National Stock Exchange of India
Shares in Issue 16,600,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
PGHL Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PGHL
Upcoming Events for PGHL
Frequently Asked Questions for Procter & Gamble Health
What is the Procter & Gamble Health share price?

As of 11:29am, shares in Procter & Gamble Health are trading at ₹5863.5, giving the company a market capitalisation of £1.02bn. This share price information is delayed by 15 minutes.

How has the Procter & Gamble Health share price performed this year?

Shares in Procter & Gamble Health are currently trading at ₹5863.5 and the price has moved by 55.78% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Procter & Gamble Health price has moved by -1.48% over the past year.

What are the analyst and broker recommendations for Procter & Gamble Health?

Of the analysts with advisory recommendations for Procter & Gamble Health, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Procter & Gamble Health is Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Procter & Gamble Health next release its financial results?

Procter & Gamble Health is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Procter & Gamble Health dividend yield?

The Procter & Gamble Health dividend yield is 0.67% based on the trailing twelve month period.

Does Procter & Gamble Health pay a dividend?

Last year, Procter & Gamble Health paid a total dividend of 42, and it currently has a trailing dividend yield of 0.67%. Looking ahead, Procter & Gamble Health has not announced an ex-dividend date yet.

When does Procter & Gamble Health next pay dividends?

Procter & Gamble Health has yet to annouce their ex-dividend date. The historic dividend yield on Procter & Gamble Health shares is currently 0.67%.

How do I buy Procter & Gamble Health shares?

To buy shares in Procter & Gamble Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Procter & Gamble Health?

Shares in Procter & Gamble Health are currently trading at ₹5863.5, giving the company a market capitalisation of £1.02bn.

Where are Procter & Gamble Health shares listed? Where are Procter & Gamble Health shares listed?

Here are the trading details for Procter & Gamble Health:

Country of listing: India
Exchange: NSI
Ticker Symbol: PGHL
What kind of share is Procter & Gamble Health?

Based on an overall assessment of its quality, value and momentum, Procter & Gamble Health is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Procter & Gamble Health share price forecast 2021?

Shares in Procter & Gamble Health are currently priced at ₹5863.5. At that level they are trading at 45.41% premium to the analyst consensus target price of 0.00.

How can I tell whether the Procter & Gamble Health share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Procter & Gamble Health. Over the past six months, the relative strength of its shares against the market has been 2.49%. At the current price of ₹5863.5, shares in Procter & Gamble Health are trading at 7.49% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Procter & Gamble Health PE Ratio?

The Procter & Gamble Health PE ratio based on its reported earnings over the past 12 months is 46.96. The shares are currently trading at ₹5863.5.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Procter & Gamble Health?

Procter & Gamble Health's management team is headed by:

Suresh Talwar - NEC
Vikas Gupta - GCN
Anand Nambiar - DRC
Bradley Simpson - NED
Milind Thatte - MDR
Amit Gupta - CFO
Hon Keong Choo - NED
Aalok Agrawal - NED
Who are the major shareholders of Procter & Gamble Health?

Here are the top five shareholders of Procter & Gamble Health based on the size of their shareholding:

Procter & Gamble Co Holding Company
Percentage owned: 51.82% (8.60m shares)
Life Insurance Corporation of India Insurance Company
Percentage owned: 3.89% (646k shares)
HDFC Asset Management Co., Ltd. Investment Advisor
Percentage owned: 2.75% (457k shares)
HDFC Small Cap Fund Mutual Fund
Percentage owned: 2.13% (353k shares)
Tata Asset Management Limited Investment Advisor
Percentage owned: 1.69% (281k shares)
Similar to PGHL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.